Cell Source Net Income Growth & History (CLCS)

Cell Source's net income was −$4.5M for fiscal 2024.

View full Cell Source company overview

Cell Source annual net income history

Cell Source annual net income

Fiscal yearPeriod endedNet incomeChangeGrowth
20242024-12-31−$4.5M$808,570
20232023-12-31−$5.3M−$153,464
20222022-12-31−$5.2M$304,687
20212021-12-31−$5.5M−$912,270
20202020-12-31−$4.6M−$84,670
20192019-12-31−$4.5M−$2.4M
20182018-12-31−$2.1M$965,064
20172017-12-31−$3.1M−$2.1M
20162016-12-31−$967,782$1.5M
20152015-12-31−$2.5M$1.6M
20142014-12-31−$4.1M−$2.3M
20132013-12-31−$1.8M

Cell Source net income trends

Over the last five fiscal years, Cell Source's net income decreased from −$4.5M to −$4.5M, a change of −$37,147. The latest reported quarter, Q1 2025, shows −$1.5M.

About the metric

What net income means

Net income is a company’s bottom-line profit or loss after operating costs, interest, taxes, and other reported income and expenses. It shows how much of a company’s revenue ultimately remained as earnings, or how large its loss was, during a fiscal period.

Calculation and source

SEC-reported net income

TickerStat standardizes consolidated net income or profit and loss reported in company SEC filings for aligned fiscal periods. It is not adjusted earnings, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cell Source source filings ↗

Community posts

It’s quiet here.

No posts about CLCS yet. Start the conversation.

Write the first post